Open AccessEarly Treatment With Darolutamide Improves Survival in Prostate Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000741788.10454.0f
Subject(s) - prostate cancer , medicine , placebo , androgen deprivation therapy , oncology , enzalutamide , clinical trial , urology , cancer , androgen receptor , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom